New Cheek Swab Test Predicts Mortality Risk with Epigenetic Clocks

Tally Health's 'CheekAge' tool uses epigenetic markers from cheek cells to estimate biological age and mortality risk.

Tally Health has developed 'CheekAge,' a non-invasive test that uses cheek swabs to predict biological age and mortality risk.
The test analyzes DNA methylation markers, which accumulate over time and affect gene expression, to determine a person's biological clock.
CheekAge has shown to be as accurate or more accurate than other existing epigenetic clocks, even when using blood samples instead of cheek cells.
The study used data from the Lothian Birth Cohorts, finding a correlation between certain methylation sites and increased mortality risk.
Researchers highlight the potential of CheekAge to provide insights into health and longevity, with implications for personalized medicine.